loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Open house drug discount agreements for the active ingredient ticagrelor, ATC B01AC24 - 605329

World Biggest Tenders Source

This tender with title Open house drug discount agreements for the active ingredient ticagrelor, ATC B01AC24 - 605329 has been published on Bidding Source portal dated 10 Sep 2026 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Open house drug discount agreements for the active ingredient ticagrelor, ATC B01AC24 - 605329
Invitation for Bids
605329
Germany
10 Sep 2026
31 Mar 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - Drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in conjunction with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the drug Factor VIII SDH (B02BD02) for the treatment of hemophilia - 606717 Germany Awarded - Drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in conjunction with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the drugs Haemoctin SDH (B02BD02) and Haemonine (B02BD04) for the treatment of hemophilia - 607005 Germany Awarded - Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient emtricitabine + rilpivirine + tenofovir disoproxil fumarate, ATC J05AR08 fd Z. 01.09.24 - 31.08.26 - 607072 Germany Awarded - Drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in conjunction with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the drug Fanhdi (B02BD06) for the treatment of hemophilia - 607378 Germany Awarded - Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient natalizumab (exclusively in Dafo injection solution, ATC L04AA23) for the period 01.09.24 - 31.08.26 - 607379 Germany Awarded - Drug discount agreement for the drugs Advate (B02BD02), Recombinate (B02BD02), Rixubis (B02BD04), Feiba (B02BD03), Immunate (B02BD06), Immuseven (B02BD05), Adynovi (B02BD02), Veyvondi (B02BD10) - 607562 Germany Awarded - Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient brinzolamide + brimonidine, ATC S01EC24, for the period 01.09.2024 - 31.08.2026 - 608080 Germany Awarded - Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient abatacept, ATC L04AA24, for the period 01.09.2024 - 31.08.2026 - 608149 Germany Awarded - Drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in conjunction with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the drugs Haemate P (B02BD06) and Voncento (B02BD06) for the treatment of hemophilia - 608165 Germany Awarded - Drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in conjunction with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the drugs Benefix (B02BD04) and ReFacto AF (B02BD02) for the treatment of hemophilia - 608195 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans